Original contribution
Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: Serial CK-MB sampling in the emergency department

https://doi.org/10.1016/S0196-0644(05)82515-6Get rights and content

Study objectives:

This study tested the hypothesis that serial creatine phosphokinase (CK)-MB sampling in the emergency department can identify acute myocardial infarction (AMI) in patients presenting to the ED with chest pain and nondiagnostic ECGs.

Design:

Patients more than 30 years old who were evaluated initially in the ED and hospitalized for chest pain were studied. Serial CK-MB levels were analyzed prospectively using a rapid serum immunochemical assay for identification of AMI patients in the ED. Presenting ECGs showing new, greater than 1-mm ST elevation in two or more contiguous leads were considered diagnostic for AMI. All other ECGs were considered nondiagnostic ECGs. CK-MB levels were determined at ED presentation and hourly for three hours (total of four levels). Patients with at least one level of more than 7 ng/mL were considered to have a positive enzyme study. The in-hospital diagnosis of AMI was determined by the development of typical serial ECG changes or separate standard cardiac enzyme changes after admission.

Setting:

Eight tertiary-care medical center hospitals. Methods and main results: Of the 616 study patients, 108 (17.5%) were diagnosed in the hospital as AMI; 69 of these AMI patients (63.9%) had nondiagnostic ECGs in the ED. Of the patients with nondiagnostic ECGs, 55 (sensitivity, 79.7%) had a positive ED serial CK-MB enzyme study within three hours after presentation. Combining serial ED CK-MB assay results with diagnostic ECGs yielded an 88.4% sensitivity for AMI detection within three hours of ED presentation. The predictive value of a negative serial ED enzyme study for no AMI was 96.2% (specificity, 93.7%).

Conclusion:

Serial CK-MB determination in the ED can help identify AMI patients with initial nondiagnostic ECGs. Use of serial CK-MB analysis may facilitate optimal in-hospital disposition and help guide therapeutic interventions in patients with suspected AMI despite a nondiagnostic ECG.

References (48)

  • RobertsR et al.

    Detection of acute myocardial infarction by radioimmunoassay for creatine kinase MB

    Lancet

    (1977)
  • TierneyW et al.

    Physician estimates of the probability of myocardial infarction in emergency room patients with chest pain

    Med Decis Making

    (1986)
  • SchorS et al.

    Dispositions of presumed coronary patients from an emergency room: A follow-up study

    JAMA

    (1976)
  • UretskyBF et al.

    Symptomatic myocardial infarction without chest pain: Prevalence and clinical course

    Am J Cardiol

    (1987)
  • BayerAJ et al.

    Changing presentation of myocardial infarction with increasing old age

    JAm Geriatr Soc

    (1986)
  • McGuinnessJB et al.

    First electrocardiogram in recent myocardial infarction

    Br Med J

    (1976)
  • ShortD

    The earliest electrocardiographic evidence of myocardial infarction

    Br Heart J

    (1970)
  • WolfL et al.

    Vectorcardiographic diagnosis: A correlation with autopsy findings in 167 cases

    Circulation

    (1961)
  • JohnsonWJ et al.

    Unrecognized myocardial infarction: A clinicopathologic study

    Arch Intern Med

    (1959)
  • ZarlingEJ et al.

    Failure to diagnose acute myocardial infarction: Clinicopathologic experience at a large community hospital

    JAMA

    (1983)
  • DunnJ

    Chest pain

    ACEPForesight

    (1986)
  • LeeTH et al.

    Evaluation of creatine kinase and creatine kinase-MB for diagnosing myocardial infarction: Clinical impact in the emergency room

    Arch Intern Med

    (1987)
  • IrvinRG et al.

    Acute myocardial infarction and MB creatine kinase: Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme

    Arch Intern Med

    (1980)
  • QualeJ et al.

    Use of sequential cardiac enzyme analysis in stratification of risk for myocardial infarction in patients with unstable angina

    Arch Intern Med

    (1988)
  • Cited by (181)

    • Acute Myocardial Infarction Biosensor: A Review From Bottom Up

      2021, Current Problems in Cardiology
      Citation Excerpt :

      In 1982 Denmark researchers evaluated the performance of the enzyme related to AMI in 321 male patients, where they found that a semiquantitative expression of the extent of myocardial necrosis was possible to be determined in vivo.74 In the 90s studies focused on early diagnosis of patients admitted in ED and the unity of coronary care presenting symptoms of chest pain, finding that the use of techniques that involves the enzyme can help to identify AMI with rapid diagnostic characterization even without a previous ECG.50,71 In more recent times, works has been reported to be center on CK-MB evaluations compared with other agents like myoglobin (MYO), TnI and plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) to see if their estimation together as a conjunct can help with acute diagnosis of AMI.

    • Echocardiography in Emergency Clinical Presentation

      2015, ASE’s Comprehensive Echocardiography
    View all citing articles on Scopus

    Supported in part by grants from Genetech, Inc, and Hybritech, Inc.

    Presented at the American College of Cardiology Scientific Assembly in Atlanta, March 1991.

    View full text